Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Israth Jahan Tuhin"'
Autor:
Jingwen Tan, Yujie Jia, Meixia Zhou, Chengcheng Fu, Israth Jahan Tuhin, Jing Ye, Masuma Akter Monty, Nan Xu, Liqing Kang, Minghao Li, Jiaqi Shao, Xiaoyan Fang, Hongjia Zhu, Lingzhi Yan, Changju Qu, Shengli Xue, Zhengming Jin, Suning Chen, Haiwen Huang, Yang Xu, Jia Chen, Miao Miao, Xiaowen Tang, Caixia Li, Zhiqiang Yan, Depei Wu, Lei Yu
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-6 (2022)
Abstract Persistence of CAR-T cell function is associated with relapse rate after CAR-T therapy, while co-stimulatory agents are highly concerned with the persistence of CAR-T cells. In this study, we designed and constructed a series of BCMA-targeti
Externí odkaz:
https://doaj.org/article/a3ee58789e894f47809e3f878bf84545
Autor:
Jing Ye, Yujie Jia, Israth Jahan Tuhin, Jingwen Tan, Masuma Akter Monty, Nan Xu, Liqing Kang, Minghao Li, Xiaoyan Lou, Meixia Zhou, Xiaoyan Fang, Jiaqi Shao, Hongjia Zhu, Zhiqiang Yan, Lei Yu
Publikováno v:
Molecular Therapy: Oncolytics, Vol 24, Iss , Pp 719-728 (2022)
Although chimeric antigen receptor (CAR) T cell immunotherapy has shown promising significance in B cell malignancies, success against T cell malignancies remains unsatisfactory because of shared antigenicity between normal and malignant T cells, res
Externí odkaz:
https://doaj.org/article/2cae61de682b4b179035d6ec2bf19cc2
Autor:
Hongjia Zhu, Xiaoyan Fang, Israth Jahan Tuhin, Jingwen Tan, Jing Ye, Yujie Jia, Nan Xu, Liqing Kang, Minghao Li, XiaoYan Lou, Jing-e Zhou, Yiting Wang, Zhiqiang Yan, Lei Yu
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:2261-2274
Purpose: Chimeric antigen receptor (CAR) T cell therapy has demonstrated clinical success in treating haematologic malignancies but has not been effective against solid tumours thus far. Trop2 is a tumour-related antigen broadly overexpressed on a va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd129cefb13206a4c5dd780c058a1033
https://doi.org/10.1007/s00432-022-04017-x
https://doi.org/10.1007/s00432-022-04017-x
Autor:
Israth Jahan Tuhin, Miao Miao, Xu Nan, Lei Yu, Jingwen Tan, Xiaowen Tang, Ariful Islam, Masuma Akter Monty, Depei Wu
Publikováno v:
British Journal of Pharmacology. 178:1741-1755
RNAi effectors (e.g., siRNA, shRNA, and miRNA) can efficiently trigger the silencing of specific genes, and its genomic alteration functions allowed to pursue clinical trials in distinct areas, including infectious diseases, neurodegenerative disorde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0b840f965d50ce03805cc37605c5019
https://doi.org/10.1111/bph.15414
https://doi.org/10.1111/bph.15414
Autor:
Jing Ye, Yujie Jia, Israth Jahan Tuhin, Jingwen Tan, Masuma Akter Monty, Nan Xu, Liqing Kang, Minghao Li, Xiaoyan Lou, Meixia Zhou, Xiaoyan Fang, Jiaqi Shao, Hongjia Zhu, Zhiqiang Yan, Lei Yu
Publikováno v:
Molecular therapy oncolytics. 24
Although chimeric antigen receptor (CAR) T cell immunotherapy has shown promising significance in B cell malignancies, success against T cell malignancies remains unsatisfactory because of shared antigenicity between normal and malignant T cells, res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9757f11ff36c3209353ec275bda97bdf
https://pubmed.ncbi.nlm.nih.gov/35317521
https://pubmed.ncbi.nlm.nih.gov/35317521
Autor:
Zhiqiang Yan, Haoyu Zou, Masuma Akter Monty, Jiaqi Shao, Lei Yu, Israth Jahan Tuhin, Luo Shenggen
Publikováno v:
Human gene therapy. 31(19-20)
High interleukin 17A (IL-17A) expression in hepatocellular carcinoma (HCC) tissue promotes HCC development. This study explores a method to inhibit HCC growth by neutralizing IL-17A in the HCC microenvironment. A novel type 5 adenoviral vector (Ad5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c81f3e281e45c4c4abb1916e596a00e0
https://pubmed.ncbi.nlm.nih.gov/32390483
https://pubmed.ncbi.nlm.nih.gov/32390483